Live From WCLC 2025: Sunday Highlights Podcast

Podcast | English | 2025 | 24 Min

Create Account

Cost

$0.00

Credit

No Credit Offered

In this special WCLC 2025 episode of Lung Cancer Considered, hosts Dr. Narjust Florez and Dr. Stephen Liu discuss daily highlights from the conference. Dr. David Planchard discusses the data that we have all been waiting for: the FLAURA-2 overall survival. Dr. Alexander Drilon shares results from the ARROS-1 study, including efficacy results and safety data for zidesamtinib, a new ROS1 inhibitor that could change the landscape in the ROS1 space.

Podcast Hosts:

Narjust Florez, MD, Associate Director of the Cancer Care Equity Program and Thoracic Medical Oncologist, Dana-Farber Cancer Institute; Assistant Professor of Medicine, Harvard Medical School, Boston, MA, USA
Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C., USA

Podcast Guests:

Alexander Drilon, MD, Memorial Sloan Kettering Cancer Center, New York, NY, USA
David Planchard, MD, PhD, Thoracic Oncologist, University of Paris Saclay, Paris, France